Drug
MK 8748
MK 8748: highest development phase Phase 3, developed by Merck. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Merck
Trials
| Drug | Phase | Indication |
|---|---|---|
| MK-8748 NCT07705555 | Phase 3 | Diabetic Retinopathy |
| MK-8748 NCT07705607 | Phase 3 | Diabetic Retinopathy |
Latest
No recent events.
Follow MK 8748 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.